Skip to main content
Cure Sickle Cell Initiative Recommendations on Common Data Elements for Sickle Cell Disease Gene Therapy Trials.
TLR8 gain-of-function: on the highway to the danger zone.
American Society of Hematology 2026 Guidelines for the Diagnosis and Management of Severe Acquired Aplastic Anemia.
Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.
ASH 2026 Guidelines for Management of Relapsed/Refractory Disease in Adolescents and Young Adults with ALL.
Outcomes following matched sibling donor transplantation for severe combined immunodeficiency: a report from the PIDTC.
Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1.
Challenges and limitations of mobilization and stem cell collection for gene therapy of sickle cell disease.
An analysis of diagnostic metabolomic profiles associated with hepatotoxicity during childhood ALL induction therapy.
Liberalizing Hospital Proximity Requirements for Children/Young Adults with Low Burden B-ALL Receiving Tisagenlecleucel.